LTBP2 and head and neck squamous cell carcinoma: In the current study, we determined both mRNA and protein expression of LTBP2 in HNSCC tissue samples by quantitative reverse transcription PCR (qRT-PCR) and tissue microarray immunohistochemistry analysis (TMA- IHC) respectively, and correlated to patients' clinical characteristics.